Teleflex/TFX

13:30
14:25
15:15
16:10
17:00
1D1W1MYTD1YMAX

About Teleflex

Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2023 sales), interventional (17%), anesthesia (13%), surgical (14%), interventional urology (11%), original-equipment manufacturing (11%), and other (10%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.

Ticker

TFX

Sector

Healthcare

Trading on

NYSE

Industry

Health Care Equipment and Supplies

Headquarters

Wayne, United States

Employees

14,500
Website
www.teleflex.com

Teleflex Metrics

BasicAdvanced
$10B
Market cap
33.89
P/E ratio
$6.23
EPS
1.12
Beta
$1.36
Dividend rate
0.64%
Dividend yield
$10B
1.12
$1.36
2.511
1.234
39.356
41.368
21.68%
4.26%
3.31%
6.87%
33.89
3.31
2.21
-12.09
23.12
0.64%
4.93%
-18.72%
5.72%
1.90%

What the Analysts think about Teleflex

Analyst Ratings

Majority rating from 15 analysts.
Hold

Teleflex Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
2.06% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$738M
-4.66%
Net income
$15M
-51.13%
Profit margin
2.06%
-48.63%

Teleflex Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 4.51%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$3.41
$3.64
$3.38
$3.21
-
Expected
$3.21
$3.27
$3.26
$3.07
$3.33
Surprise
6.32%
11.35%
3.54%
4.51%
-

Teleflex News

AllArticlesVideos

Teleflex Publishes 2023 Global Impact Report

GlobeNewsWire·2 months ago

Teleflex Expands Intraosseous Vascular Access Portfolio with New Arrow™ EZ-IO™ Intraosseous Access Procedure Tray

GlobeNewsWire·2 months ago

Outcomes From Two New Head-to-Head Randomized Controlled Trials Involving the UroLift™ System Highlight a Superior Patient Experience* Against Rezūm and Its Advantage Over Medical Therapy as an Early Intervention for BPH

GlobeNewsWire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for Teleflex stock?

Teleflex (TFX) has a market cap of $10B as of July 03, 2024.

What is the P/E ratio for Teleflex stock?

The price to earnings (P/E) ratio for Teleflex (TFX) stock is 33.89 as of July 03, 2024.

Does Teleflex stock pay dividends?

Yes, the Teleflex (TFX) stock pays dividends to shareholders. As of July 03, 2024, the dividend rate is $1.36 and the yield is 0.64%. Teleflex has a payout ratio of 21.68% on a trailing twelve-month basis.

When is the next Teleflex dividend payment date?

The next Teleflex (TFX) dividend payment date is unconfirmed.

What is the beta indicator for Teleflex?

Teleflex (TFX) has a beta rating of 1.12. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell Teleflex stock

Buy or sell Teleflex stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing